Area of research
Biomaterials · Biomedical Engineering
Research interest
Research interests include Nanoparticle-Based Drug Delivery, Nanoplatforms for cancer theranostics, Electrospun Nanofibers in Biomedical Applications, and Cancer Research and Treatments.
Self-propelled biomotors co-deliver doxorubicin liposomes and aPD-1 antibody to fight breast cancer
Curcumin-loaded hydrogels promote skin wound healing.
Biohybrids of Anoxia-Targeted Bacteria/MDPP for Enabling Targeted Synergistic Immunotherapy and Chemotherapy Against Breast Tumors.
Bacteria-Assisted Celastrol Liposomes for Effective Chemotherapy Against Lung Cancer in Mice Model.
Hyaluronic acid modified metal-organic frameworks loading cisplatin achieve combined chemodynamic therapy and chemotherapy for lung cancer.
Folate-Modified Smart Responsive Nanosystems for Enhancing Anti-Tumor Therapy Through Calcium Overload and Chemotherapy.
Self-propelled biohybrids co-deliver oxaliplatin and glucose oxidase for multimodal treatment of colon cancer
Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses.
Nanoparticle‐Based drug delivery strategies for targeted therapy to hypoxic solid tumors
An oral bioactive chitosan-decorated doxorubicin nanoparticles/bacteria bioconjugates enhance chemotherapy efficacy in an in-situ breast cancer model.
Antibody targeting of anaerobic bacteria warms cold tumors and improves the abscopal effect of radiotherapy.
Construction and Evaluation of BAL-PTX Co-Loaded Lipid Nanosystem for Promoting the Anti-Lung Cancer Efficacy of Paclitaxel and Reducing the Toxicity of Chemotherapeutic Drugs.
Construction of CXCR4 Receptor-Targeted CuFeSe<sub>2</sub> Nano Theranostic Platform and Its Application in MR/CT Dual Model Imaging and Photothermal Therapy.
Intraperitoneal administration of doxorubicin-encapsulated Brucea javanica oil nanoemulsion against malignant ascites.
Bioactive Bacteria/MOF Hybrids Can Achieve Targeted Synergistic Chemotherapy and Chemodynamic Therapy against Breast Tumors
Albumin-Modified Gold Nanoparticles as Novel Radiosensitizers for Enhancing Lung Cancer Radiotherapy.
Bacteria-Driven Tumor Microenvironment-Sensitive Nanoparticles Targeting Hypoxic Regions Enhances the Chemotherapy Outcome of Lung Cancer.
GM-CSF augmented the photothermal immunotherapeutic outcome of self-driving gold nanoparticles against a mouse CT-26 colon tumor model.
The Application of Nanotechnology in Immunotherapy based Combinations for Cancer Treatment.
In situ administration of temperature-sensitive hydrogel composite loading paclitaxel microspheres and cisplatin for the treatment of melanoma.
Effect of triple therapy with low-dose total body irradiation and hypo-fractionated radiation plus anti-programmed cell death protein 1 blockade on abscopal antitumor immune responses in breast cancer.
Self-driven bioactive hybrids co-deliver doxorubicin and indocyanine green nanoparticles for chemo/photothermal therapy of breast cancer.
Low-dose total body irradiation enhances systemic anti-tumor immunity induced by local cryotherapy.
Zinc finger and SCAN domain-containing protein 18 is a potential DNA methylation-modified tumor suppressor and biomarker in breast cancer.
Predictive value of <sup>18</sup>F-FDG PET/CT for evaluating the response to hypofractionated radiotherapy combined with PD-1 blockade in non-small cell lung cancer.
Low-Dose Total Body Irradiation Enhances Systemic Anti-tumor Immunity Induced by Local Cryotherapy
Bacteria-driven hypoxia targeting delivery of chemotherapeutic drug proving outcome of breast cancer.
Bacteria in cancer therapy: A new generation of weapons.